Faculty Publications
As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.
Total number of publications: 7,082
Enter a faculty name:
or browse faculty by school:
Administrative Offices
Graduate Schools
Health Sciences
Lander Colleges
Law Center
New York School of Career and Applied Studies (NYSCAS)
Touro University System
New York Medical College (NYMC)
Touro University California
Touro University Nevada
Gugliucci, A. (2009). "Blinding" of AMP-dependent kinase by methylglyoxal: A mechanism that allows perpetuation of hepatic insulin resistance? Medical Hypotheses, 73(6), 921-924. doi:10.1016/j.mehy.2009.06.044
Gugliucci, A. (2010). Beyond the antioxidant properties: Pomegranate juice polyphenols increase hepatocyte paraoxonase 1 secretion. Atherosclerosis, 208(1), 28-29. doi:10.1016/j.atherosclerosis.2009.09.032
Gugliucci, A. (2013). Bibliometric measures and National Institutes of Health funding at COMs, 2006-2010. Journal of the American Osteopathic Association, 113(4), 266. This material can be found here.
Gugliucci, A. (2014). Activation of paraoxonase 1 is associated with HDL remodeling ex vivo. Clinica Chimica Acta, 429, 38-45.
Gugliucci, A. (2015). Fructosa: Principal responsable de la epidemia de obesidad y diabetes? [Fructose: Main factor for the obesity and diabetes epidemic?]. In 7mo Simposio lnternacional de lnnovación y Desarrollo de Alimentos: Desafíos, avances, e innovación en el procesamiento de alimentos [7th International Symposium on Innovation and Development of Food: Challenges, progress, and innovation in food processing] (p. 33). Montevideo, Uruguay: Laboratorio Tecnológico del Uruguay.
Gugliucci, A. (2016). Fructose surges damage hepatic adenosyl-monophosphate-dependent kinase and lead to increased lipogenesis and hepatic insulin resistance. Medical Hypotheses, 93, 87-92. doi:10.1016/j.mehy.2016.05.026
Gugliucci, A. (2016). Reply to: "Unique effect for fructose on lipoprotein risk factors for cardiovascular disease in children is not demonstrated". Atherosclerosis, 255, 221-223. doi:10.1016/j.atherosclerosis.2016.10.035
Gugliucci, A. (2017). Formation of fructose-mediated advanced glycation end products and their roles in metabolic and inflammatory diseases. Advances in Nutrition, 8, 54-62. This material can be found here.
Gugliucci, A. (2017). Maternal fructose consumption can affect offspring metabolic outcomes. Journal of Physiology, 595(13), 4133-4134. This material can be found here.
Gugliucci, A., & Camps, J. (2013). New method to assess apo-lipoprotein profiles in native low-density and high-density lipoprotein subclasses. Journal of the American Osteopathic Association, 113(8), e10.
Gugliucci, A., & Kotani, K. (2013). Hyperglycemia induces high-density lipoprotein oxidation: Preliminary evidence from an ex-vivo study. Journal of the American Osteopathic Association, 113(8), e10.
Gugliucci, A., & Menini, T. (2014). The axis AGE-RAGE-soluble RAGE and oxidative stress in chronic kidney disease. In J. Camps (Ed.), Oxidative stress and inflammation in non-communicable diseases - Molecular mechanisms and perspectives in therapeutics (pp. 191-208). Cham, Switzerland: Springer. doi:10.1007/978-3-319-07320-0_14
Gugliucci, A., & Menini, T. (2015). Paraoxonase 1 and HDL maturation. Clinica Chimica Acta, 439, 5-13. doi:10.1016/j.cca.2014.09.016
Gugliucci, A., & Thornburg, R. (2009). Biosynthesis and degradation of nucleotides. In J. W. Baynes & M. H. Dominiczak (Eds.), Medical biochemistry (3rd Edition, pp. 403-412). New York, NY: Mosby-Elsevier.
Gugliucci, A., & Thornburg, R. (2014). Biosynthesis and degradation of nucleotides. In J. W. Baynes & M. H. Dominiczak (Eds.), Medical biochemistry (4th ed., pp. 407-417). Philadelphia, PA: Saunders.
Gugliucci, A., Bastos, D. H., Schulze, J., & Souza, M. F. (2009). Caffeic and chlorogenic acids in Ilex paraguariensis extracts are the main inhibitors of AGE generation by methylglyoxal in model proteins. Fitoterapia, 80(6), 339-344. doi:10.1016/j.fitote.2009.04.007
Gugliucci, A., Burk, M., & Caccavello, R. (2013). PON1 lactonase activity and differential distribution in high-density lipoprotein subclasses in the postprandial phase: A pilot study. Journal of the American Osteopathic Association, 113(8), e28.
Gugliucci, A, Caccavello, R., & Kimura, S. (2012). Soluble receptor for advanced glycation end correlates negatively with BMI in patients with end-stage renal disease undergoing hemodialysis: A mechanism for the obesity paradox? Journal of the American Osteopathic Association, 112(8), 539.
Gugliucci, A., Caccavello, R., Kotani, K., & Kimura, S. (2014). Evidence for the presence of active paraoxonase 1 in small-dense low-density lipoprotein. Redox Report, 19(4), 154-160. doi:10.1179/1351000214Y.0000000084
Gugliucci, A., Caccavello, R., Kotani, K., Sakane, N., & Kimura, S. (2013). Enzymatic assessment of paraoxonase 1 activity on HDL subclasses: A practical zymogram method to assess HDL function. Clinica Chimica Acta, 415, 162-168. doi:10.1016/j.cca.2012.10.044
Gugliucci, A., Caccavello, R., Nassar, H., Abu Ahmad, W., Sinnreich, R., & Kark, J. D. (2014). Lower PON1 lactonase activity explains part of the increased cardiovascular risk among Arab versus Jewish residents of Jerusalem. Atherosclerosis, 235(2), e174. doi:10.1016/j.atherosclerosis.2014.05.505
Gugliucci, A., Caccavello, R., Nassar, H., Abu Ahmad, W., Sinnreich, R., & Kark, J. D. (2015). Low protective PON1 lactonase activity in an Arab population with high rates of coronary heart disease and diabetes. Clinica Chimica Acta, 445, 41-47. doi:10.1016/j.cca.2015.03.012
Gugliucci, A., Hermo, R., Tsuji, M., & Kimura, S. (2006). Lower serum paraoxonase-1 activity in type 2 diabetic patients correlates with nitrated apolipoprotein A-I levels. Clinica Chimica Acta, 368(1-2), 201-202. doi:10.1016/j.cca.2006.01.011
Gugliucci, A., Kimura, S., & Kinugasa, E. (2014). HDL remodeling during hemodialysis is associated with activation of paraoxonase 1. Atherosclerosis, 235(2), e174. doi:10.1016/j.atherosclerosis.2014.05.506
Gugliucci, A., Kimura, S., Menini, T., Hermo, R., & Numaguchi, M. (2010). Serum aspirin esterase activity in cord blood and in adults. Journal of Pediatric Biochemistry, 1(1), 7-10. doi:10.3233/JPB-2010-0005